Nuveen’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.13M Buy
1,018,964
+453,420
+80% +$3.61M ﹤0.01% 1610
2025
Q4
$3.41M Buy
565,544
+360,064
+175% +$2.14M ﹤0.01% 2077
2025
Q3
$1.17M Hold
205,480
﹤0.01% 2548
2025
Q2
$1.04M Sell
205,480
-153,095
-43% -$821K ﹤0.01% 2586
2025
Q1
$2.32M Sell
358,575
-997
-0.3% -$8.87K ﹤0.01% 2280
2024
Q4
$2.64M Sell
359,572
-162,291
-31% -$1.28M ﹤0.01% 2269
2024
Q3
$3.91M Buy
521,863
+305,653
+141% +$2.65M ﹤0.01% 2104
2024
Q2
$1.92M Buy
216,210
+7,910
+4% +$75.9K ﹤0.01% 2414
2024
Q1
$2.11M Hold
208,300
﹤0.01% 2375
2023
Q4
$2.1M Buy
208,300
+2,942
+1% +$26.9K ﹤0.01% 2392
2023
Q3
$1.92M Sell
205,358
-1,378
-0.7% -$19.7K ﹤0.01% 2307
2023
Q2
$5.07M Sell
206,736
-101,187
-33% -$2.54M ﹤0.01% 1902
2023
Q1
$7.17M Sell
307,923
-185,799
-38% -$4.75M ﹤0.01% 1683
2022
Q4
$12.5M Sell
493,722
-72,659
-13% -$1.78M ﹤0.01% 1347
2022
Q3
$10.9M Sell
566,381
-99,846
-15% -$2.54M ﹤0.01% 1421
2022
Q2
$17M Sell
666,227
-124,437
-16% -$2.91M 0.01% 1160
2022
Q1
$20M Buy
790,664
+170,599
+28% +$5.06M 0.01% 1196
2021
Q4
$26M Buy
620,065
+285,300
+85% +$11.2M 0.01% 1066
2021
Q3
$14.6M Buy
334,765
+98,520
+42% +$4.27M ﹤0.01% 1500
2021
Q2
$11.2M Buy
236,245
+5,118
+2% +$233K ﹤0.01% 1802
2021
Q1
$11.8M Sell
231,127
-2,814
-1% -$152K ﹤0.01% 1691
2020
Q4
$6.26M Sell
233,941
-95,707
-29% -$3.11M ﹤0.01% 1951
2020
Q3
$11.3M Buy
329,648
+102,971
+45% +$4.43M ﹤0.01% 1445
2020
Q2
$9.29M Buy
226,677
+189,973
+518% +$6.38M ﹤0.01% 1524
2020
Q1
$1.26M Buy
36,704
+25,364
+224% +$682K ﹤0.01% 2410
2019
Q4
$143K Buy
+11,340
New +$152K ﹤0.01% 3101

Other funds holding VIR